Circulating Tumor Cell Analysis: Technical and Statistical Considerations for Application to the Clinic

por Allan, Alison L., Keeney, Michael
Publicado 2010

Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives

por Medeiros, Braeden, Allan, Alison L.
Publicado 2019

The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the “Seed” and the “Soil”?

por Chu, Jenny E., Allan, Alison L.
Publicado 2012

Recent Advances in the Molecular Characterization of Circulating Tumor Cells

por Lowes, Lori E., Allan, Alison L.
Publicado 2014

Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors

por Rodriguez-Torres, Mauricio, Allan, Alison L.
Publicado 2015

Influence of Extracellular Vesicles on Lung Stromal Cells during Breast Cancer Metastasis

por Patel, Urvi, Susman, David, Allan, Alison L.
Publicado 2023

Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response

por Bhat, Vasudeva, Allan, Alison L., Raouf, Afshin
Publicado 2019

Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis

por Kitz, Jenna, Lowes, Lori E., Goodale, David, Allan, Alison L.
Publicado 2018

EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis

por Kitz, Jenna, Goodale, David, Postenka, Carl, Lowes, Lori E., Allan, Alison L.
Publicado 2021

Lung-Derived Selectins Enhance Metastatic Behavior of Triple Negative Breast Cancer Cells

por Khan, Sami U., Xia, Ying, Goodale, David, Schoettle, Gabriella, Allan, Alison L.
Publicado 2021

Reduced Zeb1 Expression in Prostate Cancer Cells Leads to an Aggressive Partial-EMT Phenotype Associated with Altered Global Methylation Patterns

por Kitz, Jenna, Lefebvre, Cory, Carlos, Joselia, Lowes, Lori E., Allan, Alison L.
Publicado 2021

Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis

por Beausoleil, Michel S, Schulze, Erika B, Goodale, David, Postenka, Carl O, Allan, Alison L
Publicado 2011

A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics

por Wang, TianDuo, Chen, Yuanxin, Goodale, David, Allan, Alison L., Ronald, John A.
Publicado 2021

Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines

por Lefebvre, Cory, Pellizzari, Sierra, Bhat, Vasudeva, Jurcic, Kristina, Litchfield, David W., Allan, Alison L.
Publicado 2023

Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells

por Pio, Graciella M., Xia, Ying, Piaseczny, Matthew M., Chu, Jenny E., Allan, Alison L.
Publicado 2017

Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer

por Lowes, Lori E., Goodale, David, Xia, Ying, Postenka, Carl, Piaseczny, Matthew M., Paczkowski, Freeman, Allan, Alison L.
Publicado 2016

Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells

por Croker, Alysha K., Rodriguez-Torres, Mauricio, Xia, Ying, Pardhan, Siddika, Leong, Hon Sing, Lewis, John D., Allan, Alison L.
Publicado 2017

Triple-Negative Primary Breast Tumors Induce Supportive Premetastatic Changes in the Extracellular Matrix and Soluble Components of the Lung Microenvironment

por Medeiros, Braeden, Goodale, David, Postenka, Carl, Lowes, Lori E., Kiser, Patti, Hearn, Stephen, Salmond, Nikki, Williams, Karla C., Allan, Alison L.
Publicado 2020

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

por Lowes, Lori E., Bratman, Scott V., Dittamore, Ryan, Done, Susan, Kelley, Shana O., Mai, Sabine, Morin, Ryan D., Wyatt, Alexander W., Allan, Alison L.
Publicado 2016

A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209

por Eigl, Bernhard Josef, Chi, Kim, Tu, Dongsheng, Hotte, Sebastien J., Winquist, Eric, Booth, Christopher M., Canil, Christina, Potvin, Kylea, Gregg, Richard, North, Scott, Zulfiqar, Muhammad, Ellard, Susan, Ruether, Joseph Dean, Le, Lyly, Kakumanu, A. Saranya, Salim, Mohammad, Allan, Alison L., Feilotter, Harriet, Theis, Ashley, Seymour, Lesley
Publicado 2018